Holdings of GILEAD SCIENCES, INC.
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 6 in 2 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Arcellx Inc | 6,720,803 | 771.7M $ | |
| 2 | Arcus Biosciences Inc | 31,424,760 | 678.8M $ | |
| 3 | Galapagos NV | 16,707,477 | 501.2M $ | |
| 4 | Assembly Biosciences Inc | 4,505,391 | 125M $ | |
| 5 | Kyverna Therapeutics Inc | 4,126,119 | 35.6M $ | |
| 6 | XILIO THERAPEUTICS INC | 650,389 | 5.5M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 76.3 %
- Belgium 23.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 5 | 1.6B $ | 76.33 % |
| 2 | Belgium | 1 | 501.2M $ | 23.67 % |
Cite this page
Titelia. "Holdings of GILEAD SCIENCES, INC.". https://titelia.com/en/funds/US13F882095